Ovid Therapeutics Inc (NASDAQ:OVID)
| 3.65 Delayed Data As of Oct 03 |  +0.06 / +1.69%Today’s Change | 1.41 Today|||52-Week Range 4.14 | +96.24% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 11.8K | 56.5K | 80.3K | 141.7K | ||
| Operating Expenses | Gross Income | -11.8K | -56.5K | -80.3K | -141.7K | |
| General Expenses | 13.2M | 22.5M | 64.9M | 52.8M | ||
| Research And Development | 6.6M | 9.6M | 50.0M | 33.8M | ||
| Total Operating Expenses | 13.2M | 22.5M | 65.0M | 52.9M | ||
| Non-Operating Expenses | Operating Income | -13.2M | -22.5M | -65.0M | -52.9M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -13.2M | -22.4M | -64.8M | -52.0M | |
| Net Income | -13.2M | -22.4M | -64.8M | -52.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 25.4M | 25.4M | 19.3M | 24.6M | |
| Shares To Calculate EPS Diluted | 25.4M | 25.4M | 19.3M | 24.6M | ||
| Earnings Per Share | EPS | -$1.36 | -$2.28 | -$3.35 | -$2.11 | |
| EPS Diluted | -$0.52 | -$0.88 | -$3.35 | -$2.11 | ||
